Company / Cash per Share
ImmunityBio, Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.10
FY2025
5-year range
$0.09 / $0.63
FY2021-FY2025
Trend
-51.6%
vs FY2024
Sector context
#199 of 205
Health Care
What the data says
Among 205 Health Care companies, ImmunityBio, Inc. is in the bottom 3% for cash per share. Cash per Share has fluctuated over the past 10 years, ranging from $0.09 in FY2021 to $0.96 in FY2019.
Based on SEC 10-K filings.
0.10 in FY2025 with a 5-year CAGR of -21.8%.
Declined from $0.63 to $0.10 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -26.7%
- 5-Year CAGR
- -21.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 3% in Health CareTop 97% of 205This company $0.10 Sector average $67.98
▼
-99.8% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 51.6% year-over-year.
- Ranks #199 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2019.
- Lowest cash per share in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score -7.50 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.10 | -51.6% |
| FY2024 | $0.21 | -66.0% |
| FY2023 | $0.63 | +139.4% |
| FY2022 | $0.26 | +188.0% |
| FY2021 | $0.09 | -74.2% |
| FY2020 | $0.35 | -63.0% |
| FY2019 | $0.96 | +217.3% |
| FY2018 | $0.30 | +206.4% |
| FY2017 | $0.10 | -86.4% |
| FY2016 | $0.73 | -99.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026